生化基因 BIIB 深 沪
等待开盘 02-07 09:30:00 美东时间
191.7875
+6.428
+3.47%
华盛通- 最 高197.98
- 今 开187.01
- 成交量 111.99万股
- 最 低 160.3645
- 昨 收 185.36
- 总市值 2800.10万
- 52周最高 197.98
- 市盈率 静 18.44
- 换手率 767.08%
- 52周最低 0.00
- 委 比 61.33%
- 总股本 0.00亿
- 历史最高 197.98
- 量 比 3.07
- 振 幅 20.29%
- 历史最低 0.00
- 每 手 1
- 风险率 19.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump
Biogen beat fourth-quarter earnings and revenue estimates as growth from Leqembi, Skyclarys, and Zurzuvae offset declining multiple sclerosis sales, while the company forecast higher 2026 earnings.
02-06 23:33
Earnings Summary: Biogen Q4
Biogen (NASDAQ:BIIB) announced its Q4 earnings on Friday, February 6, 2026 at 0...
02-06 19:06
Amazon, AutoNation And 3 Stocks To Watch Heading Into Friday
U.S. stock futures down; AutoNation, Amazon, Philip Morris, Reddit, and Biogen expected to report quarterly earnings.
02-06 14:41
Uncovering Potential: Biogen's Earnings Preview
Biogen (NASDAQ:BIIB) is preparing to release its quarterly earnings on Friday, ...
02-05 22:02
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
01-16 01:35
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.
01-07 02:42
Reported Friday, Nasdaq-100 Index Reconstituted As Alnylam, Ferrovial, Insmed, Monolithic Power, Seagate And Western Digital Join, While Biogen, CDW, GlobalFoundries, Lululemon, ON Semiconductor And Trade Desk Exit
As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc.
2025-12-15 16:10
Why Is Biogen Stock Trading Higher After Semaglutide Alzheimer's Data?
Biogen stock rises as Novo Nordisk's Alzheimer's trials disappoint, spotlighting Leqembi's role and a new immunology collaboration with Dayra Therapeutics.
2025-11-25 00:17
Novo Nordisk Will Soon Reveal Whether Its GLP-1 Drug Can Slow Alzheimer's
Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment expectations for GLP-1 drugs.
2025-11-21 23:36
总金额超20亿美元，诺诚健华核心产品再出海
转自：贝壳财经 10月9日，诺诚健华发布公告，全资子公司InnoCare Pharma Inc.与纳斯达克上市公司Zenas BioPharma, Inc.（以...
2025-10-10 18:09
